icometrix

icometrix was founded in 2011, in Leuven, Belgium; striving for data-driven insights and personalized patient care, supported by artificial intelligence. We offer a portfolio of AI solutions to assist healthcare with various challenges in neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer's disease.

Today, we're internationally active and integrated into more than 100 clinical practices and supporting pharmaceutical companies in phase I-III and Real-World Evidence (RWE) studies.